AU2003223934A1 - Recombinant bet. v. 1. allergen mutants, methods and process thereof - Google Patents

Recombinant bet. v. 1. allergen mutants, methods and process thereof

Info

Publication number
AU2003223934A1
AU2003223934A1 AU2003223934A AU2003223934A AU2003223934A1 AU 2003223934 A1 AU2003223934 A1 AU 2003223934A1 AU 2003223934 A AU2003223934 A AU 2003223934A AU 2003223934 A AU2003223934 A AU 2003223934A AU 2003223934 A1 AU2003223934 A1 AU 2003223934A1
Authority
AU
Australia
Prior art keywords
methods
recombinant bet
allergen mutants
allergen
mutants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003223934A
Other versions
AU2003223934A8 (en
Inventor
Mercedes Ferreras
Jens Holm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
ALK Abello AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALK Abello AS filed Critical ALK Abello AS
Publication of AU2003223934A8 publication Critical patent/AU2003223934A8/en
Publication of AU2003223934A1 publication Critical patent/AU2003223934A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003223934A 2002-05-16 2003-05-15 Recombinant bet. v. 1. allergen mutants, methods and process thereof Abandoned AU2003223934A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38144002P 2002-05-16 2002-05-16
DKPA200200756 2002-05-16
US60/381,440 2002-05-16
DKPA200200756 2002-05-16
PCT/DK2003/000322 WO2003096869A2 (en) 2002-05-16 2003-05-15 Recombinant bet. v. 1. allergen mutants, methods and process thereof

Publications (2)

Publication Number Publication Date
AU2003223934A8 AU2003223934A8 (en) 2003-12-02
AU2003223934A1 true AU2003223934A1 (en) 2003-12-02

Family

ID=29551230

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003223934A Abandoned AU2003223934A1 (en) 2002-05-16 2003-05-15 Recombinant bet. v. 1. allergen mutants, methods and process thereof

Country Status (6)

Country Link
EP (1) EP1504089A2 (en)
CN (1) CN1668737A (en)
AU (1) AU2003223934A1 (en)
CA (1) CA2486112A1 (en)
PL (1) PL212139B1 (en)
WO (1) WO2003096869A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2116257T3 (en) 2000-08-09 2013-02-04 Alk Abello As Parenteral vaccine formulations and applications thereof
MXPA05005528A (en) 2002-11-26 2006-04-05 Alk Abello As Pharmaceutical allergen product.
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
BRPI0417264A (en) 2003-12-19 2007-03-06 Alk Abello As processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranes of an allergen product, and a cryogran of an allergen product
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
WO2006050729A2 (en) * 2004-11-10 2006-05-18 Alk-Abellò A/S Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
EP1933867A1 (en) 2005-10-04 2008-06-25 Alk-Abello A/S Solid vaccine formulation
ITMI20052517A1 (en) 2005-12-29 2007-06-30 Lofarma Spa VARIANBTIO HYPOALLERGENICS OF ALLERGENE GREATER BET V 1 BERRY OF BETULA VERRUCOSA
FI20075059A0 (en) 2007-01-29 2007-01-29 Valtion Teknillinen Allergen-binding monoclonal IgE antibodies and hypoallergenic genes: Immunocomplex interaction between type I IgE and allergen
EP1974746B1 (en) 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2022507A1 (en) * 2007-08-07 2009-02-11 Universität Hamburg Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy
DE202008006598U1 (en) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergy vaccine formulation for mucosal administration
EP2442828B1 (en) 2009-06-19 2016-08-03 Alk-Abelló S.A. Novel manner of administrating allergen in allergen specific immunotherapy
FI20115374A0 (en) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy New hypoallergens
FI20115375A0 (en) * 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy New hypoallergens
ITMI20111489A1 (en) * 2011-08-03 2013-02-04 Lofarma Spa HYPOALLERGENIC VARIATIONS OF ALLERGENE MORE MAL MAL 1 OF DOMESTIC MALUS
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN111718912B (en) * 2020-05-20 2021-11-02 华中农业大学 Flavanone-3-hydroxylase antigen epitope peptide, antibody and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE170630T1 (en) * 1990-12-05 1998-09-15 Novo Nordisk As PROTEINS WITH MODIFIED EPITOPES AND METHOD FOR THE PRODUCTION THEREOF
CN1332029C (en) * 1998-03-16 2007-08-15 阿尔克-阿贝洛有限公司 Mutant recombinant allergens
CA2348938A1 (en) * 1998-10-30 2000-05-11 Novozymes A/S Low allergenic protein variants
AU3717600A (en) * 1999-03-02 2000-09-21 Board Of Trustees Of The University Of Arkansas, The Methods and reagents for decreasing clinical reaction to allergy
AU2001254620A1 (en) * 2000-04-28 2001-11-12 Novozymes A/S Lipolytic enzyme variant
NZ525820A (en) * 2000-11-16 2005-01-28 Alk Abello As Mutant allergens
AU2002347369A1 (en) * 2001-12-05 2003-06-17 Circassia Limited Immunotherapeutic methods and systems

Also Published As

Publication number Publication date
WO2003096869A3 (en) 2004-04-29
CN1668737A (en) 2005-09-14
AU2003223934A8 (en) 2003-12-02
PL373086A1 (en) 2005-08-08
EP1504089A2 (en) 2005-02-09
PL212139B1 (en) 2012-08-31
WO2003096869A2 (en) 2003-11-27
CA2486112A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
AU2003223934A1 (en) Recombinant bet. v. 1. allergen mutants, methods and process thereof
AU2003210159A1 (en) Electric separator, method for the production and use thereof
AU2003286611A1 (en) Cytomodulating peptides and methods for treating neurological disorders
AU2001244609A1 (en) Novel protein, dna thereof and process for producing the same
AU2003275675A1 (en) Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same
AU3425700A (en) Non-ribosomal peptide synthetases, method for producing same and the use thereof
AU5208200A (en) Screwed connection, fastener for said connection and method for the production thereof
HK1072948A1 (en) Ifnar2 mutants, their production and use
AU2003289176A1 (en) 1,3-benzothiazinone derivatives, process for producing the same and use thereof
AU2003220967A1 (en) Conductive member and process for producing the same
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2003292099A1 (en) Iron-nickel-cobalt alloy, method for the production and use thereof
AU2003263795A1 (en) Thioredoxin mutants and uses thereof
AU2003254781A1 (en) Aminosalicylamide derivative, process for producing the same and agri-horticultural pesticide
AU2003201857A1 (en) Bisphosphine, process for producing the same, and use thereof
AU2002365189A1 (en) P85-alpha nucleic acids, polypeptides and related methods
AU2001268108A1 (en) Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
AU2003222811A1 (en) Receptacle and method for producing the same
AU2003272914A1 (en) Fine spherical particles with satisfactory molecular orientation, spherical microcapsules comprising the same, and processes for producing these
AU2002250813A1 (en) Pesticide and method for the production thereof
AU2002256705A1 (en) Corrosion-stable laminate, method for the production thereof, and its use
AU2002259238A1 (en) Dwf12 and mutants thereof
AU4776599A (en) Coccidiosis vaccine, method for the production thereof, and the use thereof
AU2003241466A1 (en) Surface-covering system and methods for making and using the same
AU2001266326A1 (en) Polypeptides, use thereof and process for producing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase